Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neurologic Manifestations × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 159 Breast Neoplasms 92 Neoplasms 66 Prostatic Neoplasms 24 Fatigue 22 Colorectal Neoplasms 17 Obesity 16 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Ovarian Neoplasms 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Multiple Myeloma 8 Lymphoma 8 Lymphedema 8 Hematologic Neoplasms 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Insulin Resistance 6 Cardiotoxicity 6 Brain Neoplasms 6 Sarcopenia 5 Esophageal Neoplasms 5 Endometrial Neoplasms 5 Breast Cancer Lymphedema 5 Weight Loss 4 Peripheral Nervous System Diseases 4 Lymphoma, Follicular 4

Interventions

Sorafenib 1 Pliability 1 Morphine 1 Methadone 1 Immunoglobulins 1 Exercise 1 Amifampridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05531695 2022-09-08

ESIBAC

Hull University Teaching Hospitals NHS Trust

Phase NA Completed

Brain Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡